Difficulty in predicting survival in metastatic renal cancer

Lancet Oncol. 2012 Sep;13(9):859-60. doi: 10.1016/S1470-2045(12)70318-2. Epub 2012 Aug 8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / mortality*
  • Female
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / mortality*
  • Male
  • Receptors, Vascular Endothelial Growth Factor / antagonists & inhibitors*

Substances

  • Receptors, Vascular Endothelial Growth Factor